<?xml version='1.0' encoding='UTF-8'?>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="dad212381" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Alzheimers Dement (Amst)</journal-id><journal-id journal-id-type="iso-abbrev">Alzheimers Dement (Amst)</journal-id><journal-id journal-id-type="pmc-domain-id">3002</journal-id><journal-id journal-id-type="pmc-domain">dadm</journal-id><journal-id journal-id-type="publisher-id">DAD2</journal-id><journal-title-group><journal-title>Alzheimer's &amp; Dementia : Diagnosis, Assessment &amp; Disease Monitoring</journal-title></journal-title-group><issn pub-type="epub">2352-8729</issn><publisher><publisher-name>Wiley</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC9720004</article-id><article-id pub-id-type="pmcid-ver">PMC9720004.1</article-id><article-id pub-id-type="pmcaid">9720004</article-id><article-id pub-id-type="pmcaiid">9720004</article-id><article-id pub-id-type="pmid">36479018</article-id><article-id pub-id-type="doi">10.1002/dad2.12381</article-id><article-id pub-id-type="publisher-id">DAD212381</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Research Articles</subject></subj-group></article-categories><title-group><article-title>Associations between diffusion MRI microstructure and cerebrospinal fluid markers of Alzheimer's disease pathology and neurodegeneration along the Alzheimer's disease continuum</article-title><alt-title alt-title-type="left-running-head">MOODY et¬†al.</alt-title></title-group><contrib-group><contrib id="dad212381-cr-0001" contrib-type="author" corresp="yes"><name name-style="western"><surname>Moody</surname><given-names initials="JF">Jason F.</given-names></name><xref rid="dad212381-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>jfmoody@wisc.edu</email></address></contrib><contrib id="dad212381-cr-0002" contrib-type="author"><name name-style="western"><surname>Dean</surname><given-names initials="DC">Douglas C.</given-names><suffix>III</suffix></name><xref rid="dad212381-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="dad212381-aff-0003" ref-type="aff">
<sup>3</sup>
</xref><xref rid="dad212381-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="dad212381-cr-0003" contrib-type="author"><name name-style="western"><surname>Kecskemeti</surname><given-names initials="SR">Steve R.</given-names></name><xref rid="dad212381-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="dad212381-cr-0004" contrib-type="author"><name name-style="western"><surname>Blennow</surname><given-names initials="K">Kaj</given-names></name><xref rid="dad212381-aff-0007" ref-type="aff">
<sup>7</sup>
</xref><xref rid="dad212381-aff-0008" ref-type="aff">
<sup>8</sup>
</xref></contrib><contrib id="dad212381-cr-0005" contrib-type="author"><name name-style="western"><surname>Zetterberg</surname><given-names initials="H">Henrik</given-names></name><xref rid="dad212381-aff-0007" ref-type="aff">
<sup>7</sup>
</xref><xref rid="dad212381-aff-0008" ref-type="aff">
<sup>8</sup>
</xref><xref rid="dad212381-aff-0009" ref-type="aff">
<sup>9</sup>
</xref><xref rid="dad212381-aff-0010" ref-type="aff">
<sup>10</sup>
</xref><xref rid="dad212381-aff-0011" ref-type="aff">
<sup>11</sup>
</xref></contrib><contrib id="dad212381-cr-0006" contrib-type="author"><name name-style="western"><surname>Kollmorgen</surname><given-names initials="G">Gwendlyn</given-names></name><xref rid="dad212381-aff-0012" ref-type="aff">
<sup>12</sup>
</xref></contrib><contrib id="dad212381-cr-0007" contrib-type="author"><name name-style="western"><surname>Suridjan</surname><given-names initials="I">Ivonne</given-names></name><xref rid="dad212381-aff-0013" ref-type="aff">
<sup>13</sup>
</xref></contrib><contrib id="dad212381-cr-0008" contrib-type="author"><name name-style="western"><surname>Wild</surname><given-names initials="N">Norbert</given-names></name><xref rid="dad212381-aff-0012" ref-type="aff">
<sup>12</sup>
</xref></contrib><contrib id="dad212381-cr-0009" contrib-type="author"><name name-style="western"><surname>Carlsson</surname><given-names initials="CM">Cynthia M.</given-names></name><xref rid="dad212381-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="dad212381-cr-0010" contrib-type="author"><name name-style="western"><surname>Johnson</surname><given-names initials="SC">Sterling C.</given-names></name><xref rid="dad212381-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="dad212381-aff-0006" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib id="dad212381-cr-0011" contrib-type="author"><name name-style="western"><surname>Alexander</surname><given-names initials="AL">Andrew L.</given-names></name><xref rid="dad212381-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="dad212381-aff-0003" ref-type="aff">
<sup>3</sup>
</xref><xref rid="dad212381-aff-0005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib id="dad212381-cr-0012" contrib-type="author"><name name-style="western"><surname>Bendlin</surname><given-names initials="BB">Barbara B.</given-names></name><xref rid="dad212381-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="dad212381-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Wisconsin Alzheimer's Disease Research Center</named-content>
<institution>University of Wisconsin‚ÄêMadison</institution>
<city>Madison</city>
<named-content content-type="country-part">Wisconsin</named-content>
<country country="US">USA</country>
</aff><aff id="dad212381-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Waisman Center</named-content>
<institution>University of Wisconsin‚ÄêMadison</institution>
<city>Madison</city>
<named-content content-type="country-part">Wisconsin</named-content>
<country country="US">USA</country>
</aff><aff id="dad212381-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Department of Medical Physics</named-content>
<institution>University of Wisconsin‚ÄêMadison</institution>
<city>Madison</city>
<named-content content-type="country-part">Wisconsin</named-content>
<country country="US">USA</country>
</aff><aff id="dad212381-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Department of Pediatrics</named-content>
<institution>University of Wisconsin‚ÄêMadison</institution>
<city>Madison</city>
<named-content content-type="country-part">Wisconsin</named-content>
<country country="US">USA</country>
</aff><aff id="dad212381-aff-0005">
<label>
<sup>5</sup>
</label>
<named-content content-type="organisation-division">Department of Psychiatry</named-content>
<institution>University of Wisconsin‚ÄêMadison</institution>
<city>Madison</city>
<named-content content-type="country-part">Wisconsin</named-content>
<country country="US">USA</country>
</aff><aff id="dad212381-aff-0006">
<label>
<sup>6</sup>
</label>
<named-content content-type="organisation-division">Geriatric Research Education and Clinical Center</named-content>
<institution>Middleton Memorial VA Hospital</institution>
<city>Madison</city>
<named-content content-type="country-part">Wisconsin</named-content>
<country country="US">USA</country>
</aff><aff id="dad212381-aff-0007">
<label>
<sup>7</sup>
</label>
<named-content content-type="organisation-division">Department of Psychiatry and Neurochemistry</named-content>
<institution>Institute of Neuroscience and Physiology</institution>
<institution>Sahlgrenska Academy</institution>
<institution>University of Gothenburg</institution>
<city>M√∂lndal</city>
<country country="SE">Sweden</country>
</aff><aff id="dad212381-aff-0008">
<label>
<sup>8</sup>
</label>
<named-content content-type="organisation-division">Clinical Neurochemistry Laboratory</named-content>
<institution>Sahlgrenska University Hospital</institution>
<city>M√∂lndal</city>
<country country="SE">Sweden</country>
</aff><aff id="dad212381-aff-0009">
<label>
<sup>9</sup>
</label>
<named-content content-type="organisation-division">Department of Neurodegenerative Disease</named-content>
<institution>UCL Institute of Neurology</institution>
<city>London</city>
<country country="GB">UK</country>
</aff><aff id="dad212381-aff-0010">
<label>
<sup>10</sup>
</label>
<named-content content-type="organisation-division">UK Dementia Research Institute</named-content>
<institution>UCL</institution>
<city>London</city>
<country country="GB">UK</country>
</aff><aff id="dad212381-aff-0011">
<label>
<sup>11</sup>
</label>
<institution>Hong Kong Center for Neurodegenerative Diseases</institution>
<city>Hong Kong</city>
<country country="CN">China</country>
</aff><aff id="dad212381-aff-0012">
<label>
<sup>12</sup>
</label>
<institution>Roche Diagnostics GmbH</institution>
<city>Penzberg</city>
<country country="DE">Germany</country>
</aff><aff id="dad212381-aff-0013">
<label>
<sup>13</sup>
</label>
<institution>Roche Diagnostics International Ltd</institution>
<city>Rotkreuz</city>
<country country="CH">Switzerland</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>Jason F. Moody, Wisconsin Alzheimer's Disease Research Center, University of Wisconsin‚ÄêMadison, 600 Highland Avenue J5/1M Clinical Science Center MC 2420, Madison, WI 53792, USA.<break/>Email: <email>jfmoody@wisc.edu</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>04</day><month>12</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>14</volume><issue seq="1130">1</issue><issue-id pub-id-type="pmc-issue-id">398532</issue-id><issue-id pub-id-type="doi">10.1002/dad2.v14.1</issue-id><elocation-id>e12381</elocation-id><history><date date-type="rev-recd"><day>14</day><month>9</month><year>2022</year></date><date date-type="received"><day>30</day><month>3</month><year>2022</year></date><date date-type="accepted"><day>29</day><month>10</month><year>2022</year></date></history><pub-history><event event-type="pmc-release"><date><day>04</day><month>12</month><year>2022</year></date></event><event event-type="pmc-live"><date><day>06</day><month>12</month><year>2022</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-09-07 13:25:37.930"><day>07</day><month>09</month><year>2024</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">¬© 2022 The Authors. <italic toggle="yes">Alzheimer's &amp; Dementia: Diagnosis, Assessment &amp; Disease Monitoring</italic> published by Wiley Periodicals, LLC on behalf of Alzheimer's Association.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="DAD2-14-e12381.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:DAD2-14-e12381.pdf"/><abstract><title>Abstract</title><sec id="dad212381-sec-0010"><title>Introduction</title><p>White matter (WM) degeneration is a critical component of early Alzheimer's disease (AD) pathophysiology. Diffusion‚Äêweighted imaging (DWI) models, including diffusion tensor imaging (DTI), neurite orientation dispersion and density imaging (NODDI), and mean apparent propagator MRI (MAP‚ÄêMRI), have the potential to identify early neurodegenerative WM changes associated with AD.</p></sec><sec id="dad212381-sec-0020"><title>Methods</title><p>We imaged 213 (198 cognitively unimpaired) aging adults with DWI and used tract‚Äêbased spatial statistics to compare 15 DWI metrics of WM microstructure to 9 cerebrospinal fluid (CSF) markers of AD pathology and neurodegeneration treated as continuous variables.</p></sec><sec id="dad212381-sec-0030"><title>Results</title><p>We found widespread WM injury in AD, as indexed by robust associations between DWI metrics and CSF biomarkers. MAP‚ÄêMRI had more spatially diffuse relationships with AŒ≤<sub>42/40</sub> and pTau, compared with NODDI and DTI.</p></sec><sec id="dad212381-sec-0040"><title>Discussion</title><p>Our results suggest that WM degeneration may be more pervasive in AD than is commonly appreciated and that innovative DWI models such as MAP‚ÄêMRI may provide clinically viable biomarkers of AD‚Äêrelated neurodegeneration in the earliest stages of AD progression.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="dad212381-kwd-0001">Alzheimer's disease</kwd><kwd id="dad212381-kwd-0002">CSF biomarkers</kwd><kwd id="dad212381-kwd-0003">diffusion MRI</kwd><kwd id="dad212381-kwd-0004">DTI</kwd><kwd id="dad212381-kwd-0005">early detection</kwd><kwd id="dad212381-kwd-0006">MAP‚ÄêMRI</kwd><kwd id="dad212381-kwd-0007">Neuro</kwd><kwd id="dad212381-kwd-0008">NODDI</kwd><kwd id="dad212381-kwd-0009">preclinical</kwd><kwd id="dad212381-kwd-0010">white matter microstructure</kwd></kwd-group><counts><fig-count count="3"/><table-count count="2"/><page-count count="11"/><word-count count="6264"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY-NC</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>2022</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.2.1 mode:remove_FC converted:05.12.2022</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="dad212381-cit-0055"><string-name name-style="western"><surname>Moody</surname><given-names>JF</given-names></string-name>, <string-name name-style="western"><surname>Dean</surname><given-names>DC</given-names></string-name>, <string-name name-style="western"><surname>Kecskemeti</surname><given-names>SR</given-names></string-name>, et¬†al. <article-title>Associations between diffusion MRI microstructure and cerebrospinal fluid markers of Alzheimer's disease pathology and neurodegeneration along the Alzheimer's disease continuum</article-title>. <source>Alzheimer's Dement</source>. <year>2022</year>;<volume>14</volume>:<elocation-id>e12381</elocation-id>. <pub-id pub-id-type="doi">10.1002/dad2.12381</pub-id><pub-id pub-id-type="pmcid">PMC9720004</pub-id><pub-id pub-id-type="pmid">36479018</pub-id></mixed-citation>
</p></notes></front><body><sec id="dad212381-sec-0050"><label>1</label><title>INTRODUCTION</title><p>Degeneration of subcortical white matter (WM) is increasingly recognized as a critical process of early Alzheimer's disease (AD) pathophysiology, with some studies suggesting that WM degeneration may precede cortical atrophy.<xref rid="dad212381-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref>, <xref rid="dad212381-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref>, <xref rid="dad212381-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>, <xref rid="dad212381-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>, <xref rid="dad212381-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref> Given that neurodegeneration is closely associated with cognitive dysfunction in AD, the discovery and development of reliable and sensitive in‚Äêvivo markers for neurodegeneration are important goals of AD research, as these prospective measures may aid in the identification of cognitively unimpaired individuals who are at risk for developing AD in the future, as well as provide crucial information pertaining to the staging and progression of AD.<xref rid="dad212381-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>
</p><p>WM changes are commonly studied using diffusion‚Äêweighted imaging (DWI), a modality that operates by sensitizing the magnetic resonance imaging (MRI) signal to the diffusion of water molecules in the brain. The most prevalent DWI model used to study WM changes associated with AD is diffusion tensor imaging (DTI).<xref rid="dad212381-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref> While DTI studies of AD have been informative, the model has known limitations, including providing limited information in regions with greater restricted (non‚ÄêGaussian) diffusion, such as that present within cellular structures.<xref rid="dad212381-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref>, <xref rid="dad212381-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref> An increasingly popular alternative to DTI applied in contemporary AD research is neurite orientation density and dispersion imaging (NODDI).<xref rid="dad212381-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref> NODDI is a biophysically‚Äêbased model which characterizes brain changes in specific microstructural environments by assuming that the DWI signal emanates from 3 distinct tissue compartments: within neurites, outside of neurites, and free water.<xref rid="dad212381-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref> The primary NODDI measures are the neurite density index (NDI ‚Äê the signal fraction from within neurites), the orientation dispersion index (ODI ‚Äê the degree of angular variation among neurites), and the isotropic volume fraction (ISO ‚Äì the signal fraction from a free water compartment). NODDI has shown promise for evaluating neurodegeneration along the clinical continuum of AD,<xref rid="dad212381-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="dad212381-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref>, <xref rid="dad212381-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref> as well as alterations along the biological spectrum of AD pathology.<xref rid="dad212381-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref>
</p><p>An alternative DWI model with minimal assumptions about tissue microstructure is mean apparent propagator (MAP) MRI.<xref rid="dad212381-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>, <xref rid="dad212381-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> In MAP‚ÄêMRI, the probability density function describing the displacements of diffusing water molecules is estimated directly from the DWI signal. MAP‚ÄêMRI measures include the return to origin probability (RTOP), the return to axis probability (RTAP), the return to plane probability (RTPP), the mean squared displacement (MSD), the Non‚ÄêGaussianity (NG), and the q‚Äêspace inverse variance (QIV).<xref rid="dad212381-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>, <xref rid="dad212381-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> RTOP quantifies the probability that a proton will remain in the same relative position in 3D space between 2 consecutive diffusion gradient pulses, and therefore, is a marker for tissue restriction. RTAP and RTPP are the 2D and 1D counterparts of RTOP and are sensitive to restrictive barriers perpendicular and parallel to the principal direction of diffusion, respectively. NG, which can similarly be decomposed into components that are perpendicular (NG<sub>‚ä•</sub>) and parallel (NG<sub>‚à•</sub>) to the principal direction of diffusion, represents the fraction of the DWI signal that does not conform to a Gaussian distribution, and therefore, serves as a barometer for complex tissue organization. MSD, another indicator of tissue restriction, is a measure of how far diffusing water molecules travel between successive diffusion gradient pulses. Finally, QIV is a measure of the variance in the diffusion signal.<xref rid="dad212381-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>, <xref rid="dad212381-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>, <xref rid="dad212381-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> Recently, MAP‚ÄêMRI has been shown to be more useful than DTI for the evaluation of Parkinson's disease severity<xref rid="dad212381-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> as well as temporal lobe epilepsy lateralization.<xref rid="dad212381-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> Additionally, 1 study found evidence that MAP‚ÄêMRI was sensitive to age‚Äêdependent amyloid burden in transgenic Alzheimer rats (TgF344‚ÄêAD),<xref rid="dad212381-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref> paving the way for future studies to explore the potential of MAP‚ÄêMRI to identify AD‚Äêrelated microstructural changes in humans.</p><p>In order to investigate WM microstructural alterations associated with AD across the brain, we applied DTI, NODDI, and for the very first time, MAP‚ÄêMRI to assess the relationships between 15 distinct diffusion parameters of WM microstructure and 9 cerebrospinal fluid (CSF) markers of AD pathology (amyloid‚Äêbeta<sub>42/40</sub> ratio [AŒ≤<sub>42/40</sub>] and phosphorylated tau [pTau]), axonal degeneration (neurofilament light chain [NfL])<xref rid="dad212381-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref>, synaptic degeneration (neurogranin,<xref rid="dad212381-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref> Œ±‚Äêsynuclein<xref rid="dad212381-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref>), and glial activation (glial fibrillary acidic protein [GFAP],<xref rid="dad212381-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref> soluble triggering receptor expressed on myeloid cells 2 [sTREM2],<xref rid="dad212381-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref> chitinase‚Äê3‚Äêlike protein 1 [YKL‚Äê40]<xref rid="dad212381-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref>). Our goal was to utilize a broad assortment of DWI markers to determine the extent to which WM microstructure is affected along the AD continuum in a largely preclinical population.</p></sec><sec id="dad212381-sec-0060"><label>2</label><title>METHODS</title><sec id="dad212381-sec-0070"><label>2.1</label><title>Participant selection</title><p>We identified 213 participants (Table¬†<xref rid="dad212381-tbl-0001" ref-type="table">1</xref>) from the Wisconsin Alzheimer's Disease Research Center (ADRC, <italic toggle="yes">n</italic>¬†=¬†95) and Wisconsin Registry for Alzheimer's Prevention study (WRAP, <italic toggle="yes">n</italic>¬†=¬†118) who underwent both multi‚Äêshell DWI and lumbar puncture. Based on neuropsychological testing and clinical criteria established by the National Institute on Aging and Alzheimer's Association, each participant was given a clinical diagnosis of cognitively unimpaired (CU, <italic toggle="yes">n</italic>¬†=¬†198), mild cognitive impairment due to AD (MCI, <italic toggle="yes">n</italic>¬†=¬†13), or AD dementia (AD, <italic toggle="yes">n</italic>¬†=¬†2). The average time between lumbar puncture and DWI scan across all participants was 142 days (median: 91, standard deviation [SD]: 125, range: 562). All study procedures were approved by The University of Wisconsin Health Sciences Institutional Review Board and all participants provided written informed consent.</p><boxed-text position="float" content-type="box" orientation="portrait"><sec id="dad212381-sec-0080"><title>RESEARCH IN CONTEXT</title><p>
<list list-type="order" id="dad212381-list-0001"><list-item><p>
<bold>Systematic review</bold>: We used PubMed to comprehensively review literature focused on diffusion‚Äêweighted imaging (DWI) studies of brain changes associated with Alzheimer's disease (AD). Numerous studies have used diffusion tensor imaging (DTI) to identify microstructural brain alterations associated with cerebrospinal fluid (CSF) markers of AD pathology and neurodegeneration. However, very few have used neurite orientation dispersion and density imaging (NODDI), and none have used mean apparent propagator (MAP) MRI. To our knowledge, this constitutes the first study of white matter (WM) changes associated with AD using MAP‚ÄêMRI.</p></list-item><list-item><p>
<bold>Interpretation</bold>: Our results suggest that WM alterations are more extensive in AD progression than is commonly appreciated and that sophisticated DWI models such as MAP‚ÄêMRI may be better suited for detecting early AD‚Äêrelated neurodegeneration than conventional DTI.</p></list-item><list-item><p>
<bold>Future directions</bold>: Studies which implement advanced DWI techniques such as MAP‚ÄêMRI may provide invaluable biomarkers for the detection of incipient pathological brain changes associated with early AD.</p></list-item></list>
</p></sec></boxed-text><table-wrap position="float" id="dad212381-tbl-0001" content-type="TABLE" orientation="portrait"><label>TABLE 1</label><caption><p>Participant demographics</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">N</italic>
</th><th align="left" rowspan="1" colspan="1">213</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Males, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">78 (36.6)</td></tr><tr><td align="left" rowspan="1" colspan="1">Females, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">135 (63.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">Age in years, Mean (SD)</td><td align="left" rowspan="1" colspan="1">64.6 (7.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">APOE</italic>¬†Œµ4 carriers, <italic toggle="yes">n</italic> (% of sample)</td><td align="left" rowspan="1" colspan="1">70 (32.9)</td></tr><tr><td align="left" rowspan="1" colspan="1">CU/MCI/AD, <italic toggle="yes">n</italic>
</td><td align="left" rowspan="1" colspan="1">198/13/2</td></tr><tr><td align="left" rowspan="1" colspan="1">CSF biomarker cutoff groups, <italic toggle="yes">n</italic> (% of sample):</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">A+/T‚àí, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">19 (8.9)</td></tr><tr><td align="left" rowspan="1" colspan="1">A‚àí/T+, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">13 (6.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">A‚àí/T‚àí, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">164 (77.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">A+/T+, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">17 (8.0)</td></tr></tbody></table><permissions><copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec><sec id="dad212381-sec-0090"><label>2.2</label><title>CSF biomarker acquisition and designation of amyloid and tau pathology status</title><p>CSF samples were collected via lumbar puncture after a minimum 4‚Äêhour fast, stored a ‚àí80¬∞C, and assayed at the Clinical Neurochemistry Laboratory, University of Gothenburg with the Roche NeuroToolKit (NTK).<xref rid="dad212381-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref> Immunoassays were performed on either a cobas e 601 analyzer (Elecsys Œ≤‚ÄêAmyloid (1‚Äê42) CSF, Œ≤‚ÄêAmyloid (1‚Äê40) CSF, Elecsys Phospho‚ÄêTau (181P) CSF) or a cobas e 411 analyzer (NfL, neurogranin, Œ±‚Äêsynuclein, GFAP, sTREM2, and YKL‚Äê40).</p><p>Cutoffs (+ or ‚àí) for amyloid (AŒ≤<sub>42/40</sub>) and tau (pTau) pathologies were established as follows: the AŒ≤<sub>42/40</sub> threshold (&lt;0.046, AŒ≤<sub>42/40</sub>+) was derived using receiver operator characteristic (ROC) curve analysis in combination with Youden's J statistic, utilizing [C‚Äê11] Pittsburgh compound B positron emission tomography imaging positivity as the standard of comparison. The pTau threshold (‚â• 24.8 pg/mL, pTau+) was designated to be 2 SD above the mean of a reference group of 223 AŒ≤<sub>42/40</sub>‚àí cognitively unimpaired younger participants whose age ranged between 45 and 60 years.<xref rid="dad212381-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref>, <xref rid="dad212381-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref>
</p></sec><sec id="dad212381-sec-0100"><label>2.3</label><title>DWI acquisition and processing</title><p>Participants were scanned on 1 of 2 3T MR750 scanners (GE Healthcare, Waukesha, WI) with 32‚Äêchannel head coils (Nova Medical; Wilmington, MA) located at either the Waisman Center (<italic toggle="yes">n</italic>
<sub>scanner1</sub>¬†=¬†59) or the Wisconsin Institute for Medical Research at UW‚ÄêHealth (<italic toggle="yes">n</italic>
<sub>scanner2</sub>¬†=¬†154), in Madison, WI. DWI images were acquired using either a 3‚Äêshell or 5‚Äêshell DWI protocol. DWI acquisition parameters are provided in Table <xref rid="dad212381-supitem-0001" ref-type="supplementary-material">S1</xref>.</p><p>All DWI images were corrected for noise,<xref rid="dad212381-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref> Gibbs ringing,<xref rid="dad212381-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref> and eddy current‚Äêinduced distortions<xref rid="dad212381-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref>, <xref rid="dad212381-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref>, <xref rid="dad212381-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref> and 5‚Äêshell images were corrected for susceptibility‚Äêinduced distortions.<xref rid="dad212381-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref> Diffusion tensors were estimated in each voxel with weighted least squares regression using <italic toggle="yes">b</italic> values¬†&lt;1500 s/mm<sup>2</sup> (i.e., the 2 inner shells) and DTI parameter maps (FA, MD, RD, AxD) were computed. The NODDI model was implemented via the Diffusion Microstructure Imaging in Python toolbox,<xref rid="dad212381-bib-0032" ref-type="bibr">
<sup>32</sup>
</xref> using d<sub>‚à•</sub>¬†=¬†1.7 ùúám2/ms, to calculate NDI, ODI, and ISO parameter maps. MAP‚ÄêMRI was applied to the diffusion data with Diffusion Imaging in Python software,<xref rid="dad212381-bib-0033" ref-type="bibr">
<sup>33</sup>
</xref> which fit the DWI signal to Hermite basis functions using a radial order of 6 and regularized the corresponding basis coefficients with the Laplacian of the reconstructed signal.<xref rid="dad212381-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> The regularized basis coefficients were utilized to calculate parameter maps of RTOP, RTAP, RTPP, MSD, NG, NG<sub>‚ä•</sub>, NG<sub>‚à•</sub>, and QIV (Figure <xref rid="dad212381-supitem-0001" ref-type="supplementary-material">S1</xref>).</p></sec><sec id="dad212381-sec-0110"><label>2.4</label><title>Tract‚Äêbased spatial statistics (TBSS) processing</title><p>In order to evaluate the relationship between all diffusion metrics and CSF biomarkers across WM regions, diffusion parameter maps were processed with the TBSS pipeline.<xref rid="dad212381-bib-0034" ref-type="bibr">
<sup>34</sup>
</xref> FA maps for all 213 participants were registered to MNI 152 1 mm<sup>3</sup> space with nonlinear registration.<xref rid="dad212381-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref> The resultant warps were used to register the other 14 diffusion parameter maps into the same space. The FA maps in MNI space were used to estimate a population mean FA (WM) skeleton via a cutoff FA value of 0.2, and all other DWI metrics were projected onto this skeleton so that statistical analysis could be performed.</p></sec><sec id="dad212381-sec-0120"><label>2.5</label><title>Data harmonization</title><p>Prior to statistical testing, all diffusion data were harmonized across scanner (scanner 1¬†vs. scanner 2) and diffusion protocol (3 shell vs. 5 shell) using neuroHarmonize software in Python.<xref rid="dad212381-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref>, <xref rid="dad212381-bib-0036" ref-type="bibr">
<sup>36</sup>
</xref> NeuroHarmonize allows for the application of the Combat algorithm, a well‚Äêestablished technique that was first introduced to remove batch‚Äêeffects in genomics,<xref rid="dad212381-bib-0037" ref-type="bibr">
<sup>37</sup>
</xref> directly to the harmonization of quantitative brain imaging data. Age and sex were specified as linear covariates, so that only the effects of scanner and diffusion protocol were minimized during the harmonization process.</p></sec><sec id="dad212381-sec-0130"><label>2.6</label><title>Linear modeling and statistics</title><p>Each imaging voxel was fit to the following general linear model (GLM) using <italic toggle="yes">Randomise</italic>
<xref rid="dad212381-bib-0038" ref-type="bibr">
<sup>38</sup>
</xref>:
<disp-formula id="dad212381-disp-0001"><label>(1)</label><mml:math id="jats-math-1" display="block"><mml:mrow><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mi>Diffusion</mml:mi><mml:mi>Paramter</mml:mi></mml:mrow></mml:mtd><mml:mtd><mml:mo>=</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mi>Œ≤</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>Œ≤</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>‚àó</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>CSF</mml:mi><mml:mi>biomarker</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>Œ≤</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>‚àó</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>Age</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd/><mml:mtd/><mml:mtd columnalign="left"><mml:mrow><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi>Œ≤</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mo>‚àó</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>sex</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo linebreak="goodbreak">+</mml:mo><mml:mi>Œµ</mml:mi></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula>
</p><p>This model is linear with respect to CSF biomarker (continuous variable) and incudes age (continuous variable) and sex (categorical variable) as covariates. All data were demeaned, and threshold‚Äêfree cluster enhancement<xref rid="dad212381-bib-0039" ref-type="bibr">
<sup>39</sup>
</xref> was utilized to identify clusters of WM skeleton voxels that exhibited significant associations between diffusion parameters and CSF biomarkers after nonparametric permutation testing (with 5000 permutations), correcting for multiple comparisons across voxels (<italic toggle="yes">P</italic>
<sub>corr</sub>¬†&lt;¬†0.05). In order to preserve statistical power, no corrections for multiple comparisons were made across DWI‚ÄêCSF associations.</p><p>The percentage of WM skeleton voxels exhibiting significant associations between diffusion parameters and CSF biomarkers were computed for each DWI‚ÄêCSF marker pair along with corresponding effect sizes (Cohen's f2). Binary masks of these voxels were created and combined to: (1) count the number of diffusion parameters significantly associated with each of AŒ≤<sub>42/42</sub>, pTau, pTau/AŒ≤<sub>42</sub>, and NfL in each WM voxel and (2) compare the composite associations of MAP‚ÄêMRI (combining associations of RTOP, RTAP, RTPP, MSD, NG, NG<sub>‚ä•</sub> NG<sub>‚à•</sub>, QIV), NODDI (combining associations of NDI, ODI, ISO), and DTI (combining associations of FA, MD, RD, AxD) metrics to AŒ≤<sub>42/42</sub>, pTau, pTau/AŒ≤<sub>42</sub>, and NfL, respectively.</p></sec><sec id="dad212381-sec-0140"><label>2.7</label><title>Supplementary analyses</title><p>We performed 4 supplementary analyses: (<xref rid="dad212381-disp-0001" ref-type="disp-formula">1</xref>) To ascertain the relationship between diffusion metrics and CSF biomarkers of AD pathology in an entirely preclinical population, we excluded all MCI and AD participants from our analysis and ran the same GLM (Equation¬†<xref rid="dad212381-disp-0001" ref-type="disp-formula">1</xref>) in the 198 cognitively unimpaired controls in our sample. (2) To increase the sensitivity of DTI metrics to CSF biomarkers, we recomputed DTI maps utilizing an additional shell of DWI data (up to <italic toggle="yes">b</italic>¬†=¬†2000 s/mm<sup>2</sup> in the 3‚Äêshell dataset and up to <italic toggle="yes">b</italic>¬†=¬†2700 s/mm<sup>2</sup> in the 5‚Äêshell dataset) and reran the GLM (Equation¬†<xref rid="dad212381-disp-0001" ref-type="disp-formula">1</xref>) with these alternative DTI maps. (3) To test the effectiveness of the data harmonization across diffusion protocols, we reran the GLM (Equation¬†<xref rid="dad212381-disp-0001" ref-type="disp-formula">1</xref>) with the 3‚Äêshell (<italic toggle="yes">n</italic>¬†=¬†153) and 5‚Äêshell (<italic toggle="yes">n</italic>¬†=¬†60) diffusion parameter maps independently and compared the number and direction (+ or ‚àí) of resultant significant relationships. (4) To gauge the strength of associations across different WM regions in the brain, we extracted DWI metrics from 3 WM ROIs (the corpus callosum [CC], cingulum [CING], and superior longitudinal fasciculus [SLF]) using the JHU ICBM WM atlas<xref rid="dad212381-bib-0040" ref-type="bibr">
<sup>40</sup>
</xref> and computed partial Pearson correlations between select DWI measures and CSF markers, correcting for age and sex.</p></sec></sec><sec id="dad212381-sec-0150"><label>3</label><title>RESULTS</title><sec id="dad212381-sec-0160"><label>3.1</label><title>Widespread associations with markers of AD pathology and axonal degeneration</title><p>Overall, there were widespread significant relationships between diffusion metrics of WM microstructure and CSF markers for amyloid plaques, phosphorylated tau proteins, and axonal degeneration across the brain (Figures¬†<xref rid="dad212381-fig-0001" ref-type="fig">1</xref>, <xref rid="dad212381-fig-0002" ref-type="fig">2</xref>, <xref rid="dad212381-fig-0003" ref-type="fig">3</xref>, Table¬†<xref rid="dad212381-tbl-0002" ref-type="table">2</xref>). CSF NfL, an indicator of axonal degeneration, was significantly associated with 9 different diffusion parameters (Positive: ODI, ISO, MSD, QIV; Negative: NDI, RTPP, NG, NG, NG<sub>‚ä•</sub>), pTau/AŒ≤<sub>42</sub> was associated with 7 parameters (Positive: ODI, QIV; Negative: NDI, RTPP, NG, NG<sub>‚ä•</sub>, NG<sub>‚à•</sub>), pTau with 6 (Positive: ODI, QIV; Negative: NDI, RTPP, NG, NG<sub>‚ä•</sub>), and AŒ≤<sub>42/40</sub> was positively associated with 4 (NDI, RTOP, NG, and NG<sub>‚ä•</sub>). Three different diffusion metrics, NG, NG<sub>‚ä•</sub>, and NDI, were each significantly associated with AŒ≤<sub>42/40</sub>, pTau, pTau/AŒ≤<sub>42</sub>, and NfL. Of note, NG<sub>‚ä•</sub> had the most extensive association with any of the 9 CSF markers among the 15 diffusion parameters assessed. Notably, 91.5% of the WM skeleton exhibited a significant relationship between NG<sub>‚ä•</sub> and pTau. Meanwhile, NG was also extensively related to pTau in 82.2% of WM skeleton voxels, while NDI was pervasively associated with pTau/AŒ≤<sub>42</sub> in 84.2% of WM skeleton voxels. Of the 9 total associations between diffusion microstructural parameters and NfL, QIV and RTPP were the most prevalent, with 83.1% and 80.6% of WM skeleton voxels related for each metric, respectively (Table¬†<xref rid="dad212381-tbl-0002" ref-type="table">2</xref>). Most of the significant DWI‚ÄêCSF relationships persisted in separate analyses of the 3‚Äêshell and 5‚Äêshell data (Tables <xref rid="dad212381-supitem-0001" ref-type="supplementary-material">S5‚ÄìS6</xref>) and 21 different DWI‚ÄêCSF marker pairs exhibited significant associations when analysis was restricted to 198 preclinical participants (Table <xref rid="dad212381-supitem-0001" ref-type="supplementary-material">S3</xref>).</p><fig position="float" fig-type="FIGURE" id="dad212381-fig-0001" orientation="portrait"><label>FIGURE 1</label><caption><p>Count of diffusion parameters having significant associations with CSF markers of AD pathology and neurodegeneration overlaid on the 1¬†mm MNI 152 standard T1 template. Each voxel is color‚Äêcoded by the number of diffusion parameters that have significant associations with the given CSF marker (top row: AŒ≤<sub>42/40</sub>, 2<sup>nd</sup> row: pTau, 3<sup>rd</sup> row: pTau/AB42, bottom row: NfL) in that voxel. WM is delineated by the mean FA skeleton of all subjects (green). Results are corrected for age, sex, and multiple comparisons across voxels with <italic toggle="yes">p</italic>¬†&lt;¬†0.05.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="DAD2-14-e12381-g001.jpg"/></fig><fig position="float" fig-type="FIGURE" id="dad212381-fig-0002" orientation="portrait"><label>FIGURE 2</label><caption><p>WM skeleton voxels (highlighted using the TBSS_fill command) with significant associations between CSF markers (top panel: AŒ≤<sub>42/40</sub>, bottom panel: pTau) and DWI Metrics (MAP‚ÄêMRI: Red, NODDI: Blue, DTI: None) overlaid on the 1¬†mm MNI 152 standard T1 template. WM is delineated by the mean FA skeleton of all subjects (green). Results are corrected for age, sex, and multiple comparisons across voxels with <italic toggle="yes">p</italic>¬†&lt;¬†0.05.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-3" orientation="portrait" xlink:href="DAD2-14-e12381-g002.jpg"/></fig><fig position="float" fig-type="FIGURE" id="dad212381-fig-0003" orientation="portrait"><label>FIGURE 3</label><caption><p>WM skeleton voxels (highlighted using the TBSS_fill command) with significant associations between CSF markers (top panel: pTau/AŒ≤<sub>42</sub>, bottom panel: NfL) and DWI metrics (MAP‚ÄêMRI: rbed, NODDI: blue, DTI: none) overlaid on the 1¬†mm MNI 152 standard T1 template. WM is delineated by the mean FA skeleton of all subjects (green). Results are corrected for age, sex, and multiple comparisons across voxels with <italic toggle="yes">p</italic>¬†&lt;¬†0.05.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-5" orientation="portrait" xlink:href="DAD2-14-e12381-g003.jpg"/></fig><table-wrap position="float" id="dad212381-tbl-0002" content-type="TABLE" orientation="portrait"><label>TABLE 2</label><caption><p>Percentage of WM skeleton voxels with significant associations (positive: bold, negative: light, or none: blank) between CSF markers and diffusion parameters of WM microstructure (corrected for age, sex, and multiple comparisons across voxels, <italic toggle="yes">p</italic>¬†&lt;¬†0.05) in 213 participants</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">CSF Marker</th><th align="left" rowspan="1" colspan="1">FA</th><th align="left" rowspan="1" colspan="1">MD</th><th align="left" rowspan="1" colspan="1">RD</th><th align="left" rowspan="1" colspan="1">AxD</th><th align="left" rowspan="1" colspan="1">NDI</th><th align="left" rowspan="1" colspan="1">ODI</th><th align="left" rowspan="1" colspan="1">ISO</th><th align="left" rowspan="1" colspan="1">RTOP</th><th align="left" rowspan="1" colspan="1">RTAP</th><th align="left" rowspan="1" colspan="1">RTPP</th><th align="left" rowspan="1" colspan="1">MSD</th><th align="left" rowspan="1" colspan="1">NG</th><th align="left" rowspan="1" colspan="1">NG<sub>‚ä•</sub>
</th><th align="left" rowspan="1" colspan="1">NG<sub>‚à•</sub>
</th><th align="left" rowspan="1" colspan="1">QIV</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">AŒ≤<sub>42</sub>/AŒ≤<sub>40</sub>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<bold>49.0</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<bold>70.6</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<bold>26.3</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>25.8</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">pTau</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">3.0</td><td align="left" rowspan="1" colspan="1">
<bold>3.0</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">8.0</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">82.2</td><td align="left" rowspan="1" colspan="1">91.5</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<bold>30.9</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">pTau/AŒ≤<sub>42</sub>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">84.2</td><td align="left" rowspan="1" colspan="1">
<bold>10.3</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">3.3</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">25.0</td><td align="left" rowspan="1" colspan="1">14.2</td><td align="left" rowspan="1" colspan="1">41.7</td><td align="left" rowspan="1" colspan="1">
<bold>62.1</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">NfL</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">77.4</td><td align="left" rowspan="1" colspan="1">
<bold>24.7</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>57.8</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">80.6</td><td align="left" rowspan="1" colspan="1">
<bold>3.7</bold>
</td><td align="left" rowspan="1" colspan="1">59.0</td><td align="left" rowspan="1" colspan="1">41.7</td><td align="left" rowspan="1" colspan="1">14.0</td><td align="left" rowspan="1" colspan="1">
<bold>83.1</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Œ±‚Äêsynuclein</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">7.6</td><td align="left" rowspan="1" colspan="1">35.5</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">sTREM2</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<bold>31.7</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>7.6</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>10.7</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">2.8</td><td align="left" rowspan="1" colspan="1">49.6</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">GFAP</td><td align="left" rowspan="1" colspan="1">
<bold>0.53</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<bold>60.6</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">9.5</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">26.5</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Neurogranin</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">YKL‚Äê40</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="dad212381-tbl2-note-0001"><p>
<italic toggle="yes">Note</italic>: That the associations between each DWI‚ÄêCSF marker pair were always in the same direction across WM voxels.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder></permissions></table-wrap><p>When the 2 inner shells of DWI data were used to fit diffusion tensors to each imaging voxel (all <italic toggle="yes">b</italic> values¬†&lt;1500 s/mm<sup>2</sup>), no DTI metrics had significant relationships with AŒ≤<sub>42/40</sub>, pTau, pTau/ AŒ≤<sub>42</sub>, or NfL that survived corrections for age, sex, and multiple comparisons across voxels (Table¬†<xref rid="dad212381-tbl-0002" ref-type="table">2</xref>). However, when incorporating an extra shell into the DTI model, RD, MD, and AxD were all positively associated with NfL, while MD and RD were positively related to pTau/AŒ≤<sub>42</sub> (Table <xref rid="dad212381-supitem-0001" ref-type="supplementary-material">S4</xref>).</p><p>WM regions with the largest number of total diffusion parameters associated with CSF markers included the CING, CC, and SLF (Figure¬†<xref rid="dad212381-fig-0001" ref-type="fig">1</xref>). Conversely, areas with the fewest number were primarily concentrated in the brainstem and peripheral brain regions. Partial correlations between select CSF markers and DWI metrics extracted from the CC, CING, and SLF ranged from weak to moderate (Figures <xref rid="dad212381-supitem-0001" ref-type="supplementary-material">S2‚ÄìS5</xref>).</p></sec><sec id="dad212381-sec-0170"><label>3.2</label><title>MAP‚ÄêMRI and sensitivity to amyloid and tau pathology</title><p>A comparison of DWI techniques revealed that MAP‚ÄêMRI metrics had particularly widespread associations with AŒ≤<sub>42/40</sub> and pTau and larger corresponding effect sizes, compared with NODDI and DTI metrics (Figure¬†<xref rid="dad212381-fig-0002" ref-type="fig">2</xref>, Table¬†<xref rid="dad212381-tbl-0002" ref-type="table">2</xref>, Table <xref rid="dad212381-supitem-0001" ref-type="supplementary-material">S2</xref>). With respect to AŒ≤<sub>42/40</sub>, 3 of the 4 diffusion indices that had significant associations with this amyloid biomarker were MAP‚ÄêMRI metrics (RTOP, NG, and NG<sub>‚ä•</sub>), with RTOP being the most prevalent. Comparably, of the 6‚Äêdiffusion metrics meaningfully related to pTau, 4 were MAP‚ÄêMRI metrics (RTPP, NG, NG<sub>‚ä•</sub>, QIV), with NG<sub>‚ä•</sub> having the most robust relationship to pTau (Table¬†<xref rid="dad212381-tbl-0002" ref-type="table">2</xref>). Despite differing sensitivities to AŒ≤<sub>42/40</sub> and pTau levels, MAP‚ÄêMRI and NODDI performed similarly in being able to detect changes in pTau/AŒ≤<sub>42</sub> across the brain (Figure¬†<xref rid="dad212381-fig-0003" ref-type="fig">3</xref>).</p></sec><sec id="dad212381-sec-0180"><label>3.3</label><title>Associations with markers of synaptic degeneration, glial activation, and inflammation</title><p>Notable associations between DWI metrics and sTREM2, GFAP, and Œ±‚Äêsynuclein were also observed. There were 5 diffusion metrics with a meaningful relationship to sTREM2 (Positive: MD, RD, AxD; Negative: NG, NG<sub>‚ä•</sub>), 4 to GFAP (Positive: FA, NDI; Negative: ISO, MSD), and 2 to Œ±‚Äêsynuclein (Negative: NG, NG<sub>‚ä•</sub>). These included particularly large associations between NG<sub>‚ä•</sub> and Œ±‚Äêsynuclein (in 35.5% of WM skeleton voxels) and sTREM2 (in 49.6% of WM skeleton voxels) as well as between NDI and GFAP (in 60.6% of WM skeleton voxels). Lastly, there were zero significant associations between any diffusion parameter and YKL‚Äê40 or neurogranin (Table¬†<xref rid="dad212381-tbl-0002" ref-type="table">2</xref>).</p></sec></sec><sec id="dad212381-sec-0190"><label>4</label><title>DISCUSSION</title><p>While MRI investigations of neurodegeneration in AD have most commonly focused on gross macrostructural brain changes, such as reduced cortical volume and thickness, there is now considerable evidence to suggest that neurodegeneration can be captured with techniques sensitive to tissue microstructure along the AD continuum even prior to cortical atrophy.<xref rid="dad212381-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref> Furthermore, studies have shown that degenerative WM microstructural changes, including axonal degeneration, demyelination, inflammation, and alterations in cellularity, are involved in AD and methods that measure these phenomena provide useful and complementary information related to the onset and progression of AD pathology. In this study, we used 3 distinct DWI techniques to identify widespread relationships between CSF markers of AD and DWI markers of WM degeneration along the AD continuum, which may suggest that little subcortical WM is spared from the effects of AD.</p><sec id="dad212381-sec-0200"><label>4.1</label><title>DWI is a clinically viable tool for identifying microstructural changes associated with AD</title><p>The widespread sensitivity of DWI microstructural metrics to CSF biomarkers of AD pathology and neurodegeneration suggests that DWI may have untapped potential in a clinical setting. For example, among our participants, NDI, NG, and NG<sub>|</sub> each had associations with at least 4 different CSF markers that covered more than 20% of the WM skeleton. The extensive associations between diffusion parameters and CSF biomarkers of AD pathology in a largely preclinical sample such as ours, suggests that these measures may hold the potential to identify the very earliest WM microstructural alterations associated with AD in cognitively unimpaired adults, years before the manifestation of cognitive and clinical symptoms of dementia. Correspondingly, after removing MCI and AD participants from our sample, over 20 associations between DWI metrics and CSF markers remained significant, including 6 diffusion metrics that were sensitive to NfL (NDI, ODI, ISO, RTPP, NG, NG<sub>‚ä•</sub>), 4 to pTau/AŒ≤<sub>42</sub> (NDI, ODI, RTOP, NG<sub>‚à•</sub>), 4 to AŒ≤<sub>42/40</sub> (NDI, RTOP, NG, NG<sub>‚ä•</sub>), and 3 to pTau (NG, NG<sub>‚ä•</sub>). While the associations were much less extensive across the WM skeleton voxels of the brain, there remained 8 different DWI indices that had some significant sensitivity to CSF markers of AD pathology or neurodegeneration, among our preclinical cohort. Notably, the diffusion imaging sequences applied in this study can be acquired in under 10 min,<xref rid="dad212381-bib-0042" ref-type="bibr">
<sup>42</sup>
</xref> making the derivation of these metrics a clinically viable tool for early detection of AD‚Äêrelated neurodegeneration.</p></sec><sec id="dad212381-sec-0210"><label>4.2</label><title>MAP‚ÄêMRI and NODDI may be sensitive to microstructural signatures of AD‚Äêrelated neurodegeneration</title><p>In our study, MAP‚ÄêMRI outperformed NODDI and DTI in detecting changes in CSF biomarkers of AD pathology and neurodegeneration across the WM fiber bundles of the brain. This may be a consequence of the fact that MAP‚ÄêMRI metrics more directly relate to the microstructural features of brain tissue and characterize non‚ÄêGaussian diffusion profiles indicative of more complex tissue organization. Therefore, these markers may be especially sensitive to common neurodegenerative changes, including those central to AD pathology, such as axonal degeneration, demyelination, inflammation, and reductions in tissue cellularity.</p><p>For example, water diffusion is highly restricted within axons, dendrites, and cellular membranes and organelles, resulting in non‚ÄêGaussian diffusion. Decreased Non‚ÄêGaussianity (NG) from MAP‚ÄêMRI suggests reduced tissue complexity and is likely a sensitive marker of axonal loss and demyelination,<xref rid="dad212381-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> which are 2 hallmark features of AD‚Äêrelated WM degeneration.<xref rid="dad212381-bib-0043" ref-type="bibr">
<sup>43</sup>
</xref>, <xref rid="dad212381-bib-0044" ref-type="bibr">
<sup>44</sup>
</xref> NfL, which was predictive of NG, NG<sub>‚ä•</sub>, and NG<sub>‚à•</sub> in our sample, is sensitive to both.<xref rid="dad212381-bib-0045" ref-type="bibr">
<sup>45</sup>
</xref>, <xref rid="dad212381-bib-0046" ref-type="bibr">
<sup>46</sup>
</xref> Moreover, NG<sub>‚ä•</sub> had a strikingly widespread association with Œ±‚Äêsynuclein, a presynaptic protein and known marker for synaptic degeneration.<xref rid="dad212381-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref> In this context, it is likely that damaged synapses (in the cortices) are concurrently affecting nearby (subcortical) WM and that NG<sub>‚ä•</sub>, by detecting subtle increases in diffusion Gaussianity in the affected area, is sensitive to this damage. Additionally, higher AŒ≤<sub>42/40</sub> levels in our sample were predictive of widespread increases in RTOP, suggesting that amyloid accumulation in AD is associated with pervasive reductions in tissue restriction.</p><p>Furthermore, MAP‚ÄêMRI and NODDI metrics exhibited widespread associations with pTau/AŒ≤<sub>42</sub>, and NfL. Notably, increases in both markers were predictive of extensive reductions in NDI, suggesting that reduced neurite density may be a characteristic feature of early AD pathology. These relationships pervaded association, commissural, projection and brainstem fiber bundles, spanning every lobule of the brain. While several studies of WM hyperintensities in AD have focused on frontal and temporal regions associated with memory and executive function,<xref rid="dad212381-bib-0047" ref-type="bibr">
<sup>47</sup>
</xref>, <xref rid="dad212381-bib-0048" ref-type="bibr">
<sup>48</sup>
</xref>, <xref rid="dad212381-bib-0049" ref-type="bibr">
<sup>49</sup>
</xref> our results suggest that WM changes in early pre‚Äêsymptomatic stagers of AD progression might be more widespread than is commonly appreciated. It is possible that the microstructural WM changes detected by DWI indices in this study are happening on a whole brain scale, in parallel with well‚Äêdocumented global atrophy of WM and gray matter structures.</p></sec><sec id="dad212381-sec-0220"><label>4.3</label><title>Limitations</title><p>A few limitations should be noted. First, we are limited by our cross‚Äêsectional study design. Ideally, we would have multiple CSF biomarker measurements and DWIs per participant, so that we could better account for individual variability in brain structure and age‚Äêrelated changes to both CSF and DWI markers. Second, some caution should be used when interpreting DWI indices and CSF biomarkers. For example, a change in RTOP may be dictated by changes in cellularity, myelination, and axonal volume.<xref rid="dad212381-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>, <xref rid="dad212381-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>, <xref rid="dad212381-bib-0050" ref-type="bibr">
<sup>50</sup>
</xref>, <xref rid="dad212381-bib-0051" ref-type="bibr">
<sup>51</sup>
</xref> Without corroborating histological studies, it can be difficult to attribute specific DWI measurements to specific tissue properties. Similarly, in a mostly preclinical cohort, pTau does not directly reflect the regional accumulation of neurofibrillary tangles and is probably, at least in part, indicative of a neuronal response to the deposition of Œ≤‚Äêamyloid proteins.<xref rid="dad212381-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref>, <xref rid="dad212381-bib-0052" ref-type="bibr">
<sup>52</sup>
</xref> As a result, it is likely that some of our DWI associations with pTau are artificially inflated by underlying amyloid pathology. Third, we did not consider the presence of WM hyperintensities (WMH) in our analysis. Because previous studies have shown that DTI<xref rid="dad212381-bib-0053" ref-type="bibr">
<sup>53</sup>
</xref> and NODDI<xref rid="dad212381-bib-0054" ref-type="bibr">
<sup>54</sup>
</xref> metrics are associated with the presence of WMH and because the majority of individuals over the age of 60 exhibit WMH,<xref rid="dad212381-bib-0053" ref-type="bibr">
<sup>53</sup>
</xref> we cannot rule out the possibility that some of our results may be influenced by uneven macrostructural WM damage between participants. Last, while data harmonization reduces the variability between DWI protocols, it cannot entirely remove protocol‚Äêdependent differences in sensitivity to tissue properties. Because of this, we assessed the associations between DWI metrics and CSF markers in the 3‚Äêshell and 5‚Äêshell cohorts independently, finding evidence that some of these relationships appear to be robust to differences in acquisition parameters.</p></sec></sec><sec sec-type="COI-statement" id="dad212381-sec-0240"><title>CONFLICT OF INTEREST</title><p>H.Z. has served at scientific advisory boards and/or as a consultant for Abbvie, Alector, Annexon, Artery Therapeutics, AZTherapies, CogRx, Denali, Eisai, Nervgen, Novo Nordisk, Pinteon Therapeutics, Red Abbey Labs, Passage Bio, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures in symposia sponsored by Cellectricon, Fujirebio, Alzecure, Biogen, and Roche, and is a co‚Äêfounder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work). K.B. has served as a consultant, at advisory boards, or at data monitoring committees for Abcam, Axon, BioArctic, Biogen, JOMDD/Shimadzu. Julius Clinical, Lilly, MagQu, Novartis, Ono Pharma, Pharmatrophix, Prothena, Roche Diagnostics, and Siemens Healthineers, and is a co‚Äêfounder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program, outside the work presented in this paper. All other authors have no competing interests to disclose. Author disclosures are available in the <xref rid="dad212381-supitem-0001" ref-type="supplementary-material">supporting information</xref>.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="dad212381-supitem-0001" position="float" content-type="local-data" orientation="portrait"><caption><p>Supplementary Information</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="DAD2-14-e12381-s001.pdf" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="dad212381-supitem-0002" position="float" content-type="local-data" orientation="portrait"><caption><p>Supplementary Information</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="DAD2-14-e12381-s002.docx" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack id="dad212381-sec-0230"><title>ACKNOWLEDGMENTS</title><p>First and foremost, we thank the research participants at the UW ADRC and WRAP for their commitment and willingness to participate in this study. We also thank the research staff at the UW ADRC for their assistance in study organization, participant recruitment, facilitating data availability, and technical support. The Roche NTK is a panel of robust prototype biomarker assays designed to evaluate key pathologic events characteristic of AD and other neurological disorders, used for research purposes only and not approved for clinical use. ELECSYS and COBAS are trademarks of Roche. All other trademarks are property of their respective owners. This research was supported by Roche Diagnostics International Ltd (Rotkreuz, Switzerland), NIH grants R01AG037639 (to BBB), R01AG027161 (to SCJ), P30 AG062715, P50 HD105353 (Waisman Center Core Grant), and the Geriatric Research, Education, and Clinical Center of the William S. Middleton Memorial Veterans Hospital. JFM was supported by the National Institute of General Medical Sciences (NIH/NIGMS) ‚Äê Initiative for Maximizing Student Development (IMSD ‚Äì Grant No. R25 GM083252), the Biology of Aging and Age‚ÄêRelated Diseases Training Grant¬†(Grant No. T32 AG000213), and the SciMed Graduate Research Scholars Fellowship. HZ is a Wallenberg Scholar supported by grants from the Swedish Research Council (#2018‚Äê02532), the European Research Council (#681712), Swedish State Support for Clinical Research (#ALFGBG‚Äê720931), the Alzheimer Drug Discovery Foundation (ADDF), USA (#201809‚Äê2016862), the AD Strategic Fund and the Alzheimer's Association (#ADSF‚Äê21‚Äê831376‚ÄêC, #ADSF‚Äê21‚Äê831381‚ÄêC and #ADSF‚Äê21‚Äê831377‚ÄêC), the Olav Thon Foundation, the Erling‚ÄêPersson Family Foundation, Stiftelsen f√∂r Gamla Tj√§narinnor, Hj√§rnfonden, Sweden (#FO2019‚Äê0228), the European Union's Horizon 2020 research and innovation programme under the Marie Sk≈Çodowska‚ÄêCurie grant agreement No 860197 (MIRIADE), European Union Joint Program for Neurodegenerative Disorders (JPND2021‚Äê00694), and the UK Dementia Research Institute at UCL. KB is supported by the Swedish Research Council (#2017‚Äê00915), the Alzheimer Drug Discovery Foundation (ADDF), USA (#RDAPB‚Äê201809‚Äê2016615), the Swedish Alzheimer Foundation (#AF‚Äê930351, #AF‚Äê939721 and #AF‚Äê968270), Hj√§rnfonden, Sweden (#FO2017‚Äê0243 and #ALZ2022‚Äê0006), the Swedish state under the agreement between the Swedish government and the County Councils, the ALF‚Äêagreement (#ALFGBG‚Äê715986 and #ALFGBG‚Äê965240), the European Union Joint Program for Neurodegenerative Disorders (JPND2019‚Äê466‚Äê236), the National Institute of Health (NIH), USA, (grant #1R01AG068398‚Äê01), and the Alzheimer's Association 2021 Zenith Award (ZEN‚Äê21‚Äê848495).</p></ack><ref-list id="dad212381-bibl-0001"><title>REFERENCES</title><ref id="dad212381-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="dad212381-cit-0001"><string-name name-style="western"><surname>Agosta</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Pievani</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Sala</surname><given-names>S</given-names></string-name>, et¬†al. <article-title>White matter damage in Alzheimer disease and its relationship to gray matter atrophy</article-title>. <source>Radiology</source>. <year>2011</year>;<volume>258</volume>(<issue>3</issue>):<fpage>853</fpage>‚Äê<lpage>863</lpage>. doi:<pub-id pub-id-type="doi">10.1148/radiol.10101284</pub-id><pub-id pub-id-type="pmid">21177393</pub-id></mixed-citation></ref><ref id="dad212381-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="dad212381-cit-0002"><string-name name-style="western"><surname>Canu</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>McLaren</surname><given-names>DG</given-names></string-name>, <string-name name-style="western"><surname>Fitzgerald</surname><given-names>ME</given-names></string-name>, et¬†al. <article-title>Microstructural diffusion changes are independent of macrostructural volume loss in moderate to severe Alzheimer's disease</article-title>. <source>J Alzheimers Dis</source>. <year>2010</year>;<volume>19</volume>(<issue>3</issue>):<fpage>963</fpage>‚Äê<lpage>976</lpage>. doi:<pub-id pub-id-type="doi">10.3233/JAD-2010-1295</pub-id><pub-id pub-id-type="pmid">20157252</pub-id><pub-id pub-id-type="pmcid">PMC2889147</pub-id></mixed-citation></ref><ref id="dad212381-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="dad212381-cit-0003"><string-name name-style="western"><surname>Maier‚ÄêHein</surname><given-names>KH</given-names></string-name>, <string-name name-style="western"><surname>Westin</surname><given-names>CF</given-names></string-name>, <string-name name-style="western"><surname>Shenton</surname><given-names>ME</given-names></string-name>, et¬†al. <article-title>Widespread white matter degeneration preceding the onset of dementia</article-title>. <source>Alzheimers Dement</source>. <year>2015</year>;<volume>11</volume>(<issue>5</issue>):<fpage>485</fpage>‚Äê<lpage>493.e2</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jalz.2014.04.518</pub-id><pub-id pub-id-type="pmid">25035154</pub-id><pub-id pub-id-type="pmcid">PMC4295016</pub-id></mixed-citation></ref><ref id="dad212381-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="dad212381-cit-0004"><string-name name-style="western"><surname>Salat</surname><given-names>DH</given-names></string-name>, <string-name name-style="western"><surname>Tuch</surname><given-names>DS</given-names></string-name>, <string-name name-style="western"><surname>van der Kouwe</surname><given-names>AJW</given-names></string-name>, et¬†al. <article-title>White matter pathology isolates the hippocampal formation in Alzheimer's disease</article-title>. <source>Neurobiol Aging</source>. <year>2010</year>;<volume>31</volume>(<issue>2</issue>):<fpage>244</fpage>‚Äê<lpage>256</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2008.03.013</pub-id><pub-id pub-id-type="pmid">18455835</pub-id><pub-id pub-id-type="pmcid">PMC3038572</pub-id></mixed-citation></ref><ref id="dad212381-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="dad212381-cit-0005"><string-name name-style="western"><surname>Stricker</surname><given-names>NH</given-names></string-name>, <string-name name-style="western"><surname>Salat</surname><given-names>DH</given-names></string-name>, <string-name name-style="western"><surname>Foley</surname><given-names>JM</given-names></string-name>, et¬†al. <article-title>Decreased white matter integrity in neuropsychologically defined mild cognitive impairment is independent of cortical thinning</article-title>. <source>J Int Neuropsychol Soc</source>. <year>2013</year>;<volume>19</volume>(<issue>8</issue>):<fpage>925</fpage>‚Äê<lpage>937</lpage>. doi:<pub-id pub-id-type="doi">10.1017/S1355617713000660</pub-id><pub-id pub-id-type="pmid">23809097</pub-id><pub-id pub-id-type="pmcid">PMC4356249</pub-id></mixed-citation></ref><ref id="dad212381-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="dad212381-cit-0006"><string-name name-style="western"><surname>Alm</surname><given-names>KH</given-names></string-name>, <string-name name-style="western"><surname>Bakker</surname><given-names>A</given-names></string-name>. <article-title>Relationships between diffusion tensor imaging and cerebrospinal fluid metrics in early stages of the Alzheimer's disease continuum</article-title>. <source>J Alzheimers Dis</source>. <year>2019</year>;<volume>70</volume>(<issue>4</issue>):<fpage>965</fpage>‚Äê<lpage>981</lpage>. doi:<pub-id pub-id-type="doi">10.3233/JAD-181210</pub-id><pub-id pub-id-type="pmid">31306117</pub-id><pub-id pub-id-type="pmcid">PMC6860011</pub-id></mixed-citation></ref><ref id="dad212381-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="dad212381-cit-0007"><string-name name-style="western"><surname>Jones</surname><given-names>DK</given-names></string-name>, <string-name name-style="western"><surname>Kn√∂sche</surname><given-names>TR</given-names></string-name>, <string-name name-style="western"><surname>Turner</surname><given-names>R</given-names></string-name>. <article-title>White matter integrity, fiber count, and other fallacies: the do's and don'ts of diffusion MRI</article-title>. <source>Neuroimage</source>. <year>2013</year>;<volume>73</volume>:<fpage>239</fpage>‚Äê<lpage>254</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroimage.2012.06.081</pub-id><pub-id pub-id-type="pmid">22846632</pub-id></mixed-citation></ref><ref id="dad212381-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="dad212381-cit-0008"><string-name name-style="western"><surname>Alexander</surname><given-names>AL</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>Lazar</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Field</surname><given-names>AS</given-names></string-name>. <article-title>Diffusion tensor imaging of the brain</article-title>. <source>Neurotherapeutics</source>. <year>2007</year>;<volume>4</volume>(<issue>3</issue>):<fpage>316</fpage>‚Äê<lpage>329</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.nurt.2007.05.011</pub-id><pub-id pub-id-type="pmid">17599699</pub-id><pub-id pub-id-type="pmcid">PMC2041910</pub-id></mixed-citation></ref><ref id="dad212381-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="dad212381-cit-0009"><string-name name-style="western"><surname>Zhang</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Schneider</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Wheeler‚ÄêKingshott</surname><given-names>CA</given-names></string-name>, <string-name name-style="western"><surname>Alexander</surname><given-names>DC</given-names></string-name>. <article-title>NODDI: practical in vivo neurite orientation dispersion and density imaging of the human brain</article-title>. <source>NeuroImage</source>. <year>2012</year>;<volume>61</volume>(<issue>4</issue>):<fpage>1000</fpage>‚Äê<lpage>1016</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroimage.2012.03.072</pub-id><pub-id pub-id-type="pmid">22484410</pub-id></mixed-citation></ref><ref id="dad212381-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="dad212381-cit-0010"><string-name name-style="western"><surname>Vogt</surname><given-names>NM</given-names></string-name>, <string-name name-style="western"><surname>Hunt</surname><given-names>JF</given-names></string-name>, <string-name name-style="western"><surname>Adluru</surname><given-names>N</given-names></string-name>, et¬†al. <article-title>Cortical microstructural alterations in mild cognitive impairment and Alzheimer's disease dementia</article-title>. <source>Cerebral Cortex</source>. <year>2020</year>;<volume>30</volume>(<issue>5</issue>):<fpage>2948</fpage>‚Äê<lpage>2960</lpage>. doi:<pub-id pub-id-type="doi">10.1093/cercor/bhz286</pub-id><pub-id pub-id-type="pmid">31833550</pub-id><pub-id pub-id-type="pmcid">PMC7197091</pub-id></mixed-citation></ref><ref id="dad212381-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="dad212381-cit-0011"><string-name name-style="western"><surname>Parker</surname><given-names>TD</given-names></string-name>, <string-name name-style="western"><surname>Slattery</surname><given-names>CF</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>J</given-names></string-name>, et¬†al. <article-title>Cortical microstructure in young onset Alzheimer's disease using neurite orientation dispersion and density imaging</article-title>. <source>Hum Brain Mapp</source>. <year>2018</year>;<volume>39</volume>(<issue>7</issue>):<fpage>3005</fpage>‚Äê<lpage>3017</lpage>. doi:<pub-id pub-id-type="doi">10.1002/hbm.24056</pub-id><pub-id pub-id-type="pmid">29575324</pub-id><pub-id pub-id-type="pmcid">PMC6055830</pub-id></mixed-citation></ref><ref id="dad212381-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="dad212381-cit-0012"><string-name name-style="western"><surname>Fu</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Shrestha</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname><given-names>M</given-names></string-name>, et¬†al. <article-title>Microstructural white matter alterations in mild cognitive impairment and Alzheimer's disease</article-title>. <source>Clin Neuroradiol</source>. <year>2020</year>;<volume>30</volume>(<issue>3</issue>):<fpage>569</fpage>‚Äê<lpage>579</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00062-019-00805-0</pub-id><pub-id pub-id-type="pmid">31175374</pub-id></mixed-citation></ref><ref id="dad212381-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="dad212381-cit-0013"><string-name name-style="western"><surname>Vogt</surname><given-names>NM</given-names></string-name>, <string-name name-style="western"><surname>Hunt</surname><given-names>JFV</given-names></string-name>, <string-name name-style="western"><surname>Adluru</surname><given-names>N</given-names></string-name>, et¬†al. <article-title>Interaction of amyloid and tau on cortical microstructure in cognitively unimpaired adults</article-title>. <source>Alzheimers Dement</source>. <year>2022</year>;<volume>18</volume>(<issue>1</issue>):<fpage>65</fpage>‚Äê<lpage>76</lpage>. doi:<pub-id pub-id-type="doi">10.1002/alz.12364</pub-id><pub-id pub-id-type="pmid">33984184</pub-id><pub-id pub-id-type="pmcid">PMC8589921</pub-id></mixed-citation></ref><ref id="dad212381-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="dad212381-cit-0014"><string-name name-style="western"><surname>√ñzarslan</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Koay</surname><given-names>CG</given-names></string-name>, <string-name name-style="western"><surname>Shepherd</surname><given-names>TM</given-names></string-name>, et¬†al. <article-title>Mean apparent propagator (MAP) MRI: a novel diffusion imaging method for mapping tissue microstructure</article-title>. <source>Neuroimage</source>. <year>2013</year>;<volume>78</volume>:<fpage>16</fpage>‚Äê<lpage>32</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroimage.2013.04.016</pub-id><pub-id pub-id-type="pmid">23587694</pub-id><pub-id pub-id-type="pmcid">PMC4059870</pub-id></mixed-citation></ref><ref id="dad212381-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="dad212381-cit-0015"><string-name name-style="western"><surname>Avram</surname><given-names>AV</given-names></string-name>, <string-name name-style="western"><surname>Sarlls</surname><given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>Barnett</surname><given-names>AS</given-names></string-name>, et¬†al. <article-title>Clinical feasibility of using mean apparent propagator (MAP) MRI to characterize brain tissue microstructure</article-title>. <source>NeuroImage</source>. <year>2016</year>;<volume>127</volume>:<fpage>422</fpage>‚Äê<lpage>434</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroimage.2015.11.027</pub-id><pub-id pub-id-type="pmid">26584864</pub-id><pub-id pub-id-type="pmcid">PMC4755846</pub-id></mixed-citation></ref><ref id="dad212381-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="dad212381-cit-0016"><string-name name-style="western"><surname>Fick</surname><given-names>RHJ</given-names></string-name>, <string-name name-style="western"><surname>Wassermann</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Caruyer</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Deriche</surname><given-names>R</given-names></string-name>. <article-title>MAPL: tissue microstructure estimation using Laplacian‚Äêregularized MAP‚ÄêMRI and its application to HCP data</article-title>. <source>Neuroimage</source>. <year>2016</year>;<volume>134</volume>:<fpage>365</fpage>‚Äê<lpage>385</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroimage.2016.03.046</pub-id><pub-id pub-id-type="pmid">27043358</pub-id></mixed-citation></ref><ref id="dad212381-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="dad212381-cit-0017"><string-name name-style="western"><surname>Le</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Zeng</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>H</given-names></string-name>, et¬†al. <article-title>Mean apparent propagator MRI is better than conventional diffusion tensor imaging for the evaluation of Parkinson's disease: a prospective pilot study</article-title>. <source>Front Aging Neurosci</source>. <year>2020</year>;<volume>12</volume>:<fpage>306</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fnagi.2020.563595</pub-id><pub-id pub-id-type="pmcid">PMC7541835</pub-id><pub-id pub-id-type="pmid">33192458</pub-id></mixed-citation></ref><ref id="dad212381-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="dad212381-cit-0018"><string-name name-style="western"><surname>Ma</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>H</given-names></string-name>, et¬†al. <article-title>Mean apparent propagator‚ÄêMRI: a new diffusion model which improves temporal lobe epilepsy lateralization</article-title>. <source>Eur J Radiol</source>. <year>2020</year>;<volume>126</volume>:<elocation-id>108914</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.ejrad.2020.108914</pub-id><pub-id pub-id-type="pmid">32197137</pub-id></mixed-citation></ref><ref id="dad212381-bib-0019"><label>19</label><mixed-citation publication-type="book" id="dad212381-cit-0019"><string-name name-style="western"><surname>Fick</surname><given-names>RHJ</given-names></string-name>, <string-name name-style="western"><surname>Daianu</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Pizzolato</surname><given-names>M</given-names></string-name>. <part-title>Comparison of biomarkers in transgenic Alzheimer rats using multi‚Äêshell diffusion MRI</part-title>. In: <person-group person-group-type="editor"><string-name name-style="western"><surname>Fuster</surname><given-names>A</given-names></string-name></person-group>, <person-group person-group-type="editor"><string-name name-style="western"><surname>Ghosh</surname><given-names>A</given-names></string-name></person-group>, <person-group person-group-type="editor"><string-name name-style="western"><surname>Kaden</surname><given-names>E</given-names></string-name></person-group>, <person-group person-group-type="editor"><string-name name-style="western"><surname>Rathi</surname><given-names>Y</given-names></string-name></person-group>, <person-group person-group-type="editor"><string-name name-style="western"><surname>Reisert</surname><given-names>M</given-names></string-name></person-group>, eds. <source>Computational Diffusion MRI</source>. <publisher-name>Mathematics and Visualization. Springer International Publishing</publisher-name>; <year>2017</year>:<fpage>187</fpage>‚Äê<lpage>199</lpage>. doi:<pub-id pub-id-type="doi">10.1007/978-3-319-54130-3_16</pub-id></mixed-citation></ref><ref id="dad212381-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="dad212381-cit-0020"><string-name name-style="western"><surname>lan</surname><given-names>XiongY</given-names></string-name>, <string-name name-style="western"><surname>T</surname><given-names>Meng</given-names></string-name>, <string-name name-style="western"><surname>Luo</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><given-names>ZhangH</given-names></string-name><article-title>The potential of neurofilament light as a biomarker in Alzheimer's disease</article-title>. <source>ENE</source>. <year>2021</year>;<volume>84</volume>(<issue>1</issue>):<fpage>6</fpage>‚Äê<lpage>15</lpage>. doi:<pub-id pub-id-type="doi">10.1159/000513008</pub-id><pub-id pub-id-type="pmid">33477142</pub-id></mixed-citation></ref><ref id="dad212381-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="dad212381-cit-0021"><string-name name-style="western"><surname>Casaletto</surname><given-names>KB</given-names></string-name>, <string-name name-style="western"><surname>Elahi</surname><given-names>FM</given-names></string-name>, <string-name name-style="western"><surname>Bettcher</surname><given-names>BM</given-names></string-name>, et¬†al. <article-title>Neurogranin, a synaptic protein, is associated with memory independent of Alzheimer biomarkers</article-title>. <source>Neurology</source>. <year>2017</year>;<volume>89</volume>(<issue>17</issue>):<fpage>1782</fpage>‚Äê<lpage>1788</lpage>. doi:<pub-id pub-id-type="doi">10.1212/WNL.0000000000004569</pub-id><pub-id pub-id-type="pmid">28939668</pub-id><pub-id pub-id-type="pmcid">PMC5664306</pub-id></mixed-citation></ref><ref id="dad212381-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="dad212381-cit-0022"><string-name name-style="western"><surname>Twohig</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Nielsen</surname><given-names>HM</given-names></string-name>. <article-title>Œ±‚Äêsynuclein in the pathophysiology of Alzheimer's disease</article-title>. <source>Mol Neurodegener</source>. <year>2019</year>;<volume>14</volume>(<issue>1</issue>):<fpage>23</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13024-019-0320-x</pub-id><pub-id pub-id-type="pmid">31186026</pub-id><pub-id pub-id-type="pmcid">PMC6558879</pub-id></mixed-citation></ref><ref id="dad212381-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="dad212381-cit-0023"><string-name name-style="western"><surname>Teitsdottir</surname><given-names>UD</given-names></string-name>, <string-name name-style="western"><surname>Jonsdottir</surname><given-names>MK</given-names></string-name>, <string-name name-style="western"><surname>Lund</surname><given-names>SH</given-names></string-name>, <string-name name-style="western"><surname>Darreh‚ÄêShori</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Snaedal</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Petersen</surname><given-names>PH</given-names></string-name>. <article-title>Association of glial and neuronal degeneration markers with Alzheimer's disease cerebrospinal fluid profile and cognitive functions</article-title>. <source>Alzheimers Res Ther</source>. <year>2020</year>;<volume>12</volume>(<issue>1</issue>):<fpage>92</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13195-020-00657-8</pub-id><pub-id pub-id-type="pmid">32753068</pub-id><pub-id pub-id-type="pmcid">PMC7404927</pub-id></mixed-citation></ref><ref id="dad212381-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="dad212381-cit-0024"><string-name name-style="western"><surname>Rauchmann</surname><given-names>BS</given-names></string-name>, <string-name name-style="western"><surname>Sadlon</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Perneczky</surname><given-names>R</given-names></string-name>. <article-title>Alzheimer's disease neuroimaging initiative. Soluble TREM2 and inflammatory proteins in Alzheimer's disease cerebrospinal fluid</article-title>. <source>J Alzheimers Dis</source>. <year>2020</year>;<volume>73</volume>(<issue>4</issue>):<fpage>1615</fpage>‚Äê<lpage>1626</lpage>. doi:<pub-id pub-id-type="doi">10.3233/JAD-191120</pub-id><pub-id pub-id-type="pmid">31958095</pub-id></mixed-citation></ref><ref id="dad212381-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="dad212381-cit-0025"><string-name name-style="western"><surname>Craig‚ÄêSchapiro</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Perrin</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Roe</surname><given-names>CM</given-names></string-name>, et¬†al. <article-title>YKL‚Äê40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease</article-title>. <source>Biol Psychiatry</source>. <year>2010</year>;<volume>68</volume>(<issue>10</issue>):<fpage>903</fpage>‚Äê<lpage>912</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.biopsych.2010.08.025</pub-id><pub-id pub-id-type="pmid">21035623</pub-id><pub-id pub-id-type="pmcid">PMC3011944</pub-id></mixed-citation></ref><ref id="dad212381-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="dad212381-cit-0026"><string-name name-style="western"><surname>Van Hulle</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Jonaitis</surname><given-names>EM</given-names></string-name>, <string-name name-style="western"><surname>Betthauser</surname><given-names>TJ</given-names></string-name>, et¬†al. <article-title>An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuum</article-title>. <source>Alzheimers Dement</source>. <year>2021</year>;<volume>17</volume>(<issue>3</issue>):<fpage>431</fpage>‚Äê<lpage>445</lpage>. doi:<pub-id pub-id-type="doi">10.1002/alz.12204</pub-id><pub-id pub-id-type="pmid">33336877</pub-id><pub-id pub-id-type="pmcid">PMC8016695</pub-id></mixed-citation></ref><ref id="dad212381-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="dad212381-cit-0027"><string-name name-style="western"><surname>Tournier</surname><given-names>JD</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Raffelt</surname><given-names>D</given-names></string-name>, et¬†al. <article-title>MRtrix3: a fast, flexible and open software framework for medical image processing and visualisation</article-title>. <source>NeuroImage</source>. <year>2019</year>;<volume>202</volume>:<elocation-id>116137</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroimage.2019.116137</pub-id><pub-id pub-id-type="pmid">31473352</pub-id></mixed-citation></ref><ref id="dad212381-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="dad212381-cit-0028"><string-name name-style="western"><surname>Andersson</surname><given-names>JLR</given-names></string-name>, <string-name name-style="western"><surname>Sotiropoulos</surname><given-names>SN</given-names></string-name>. <article-title>An integrated approach to correction for off‚Äêresonance effects and subject movement in diffusion MR imaging</article-title>. <source>Neuroimage</source>. <year>2016</year>;<volume>125</volume>:<fpage>1063</fpage>‚Äê<lpage>1078</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroimage.2015.10.019</pub-id><pub-id pub-id-type="pmid">26481672</pub-id><pub-id pub-id-type="pmcid">PMC4692656</pub-id></mixed-citation></ref><ref id="dad212381-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="dad212381-cit-0029"><string-name name-style="western"><surname>Andersson</surname><given-names>JLR</given-names></string-name>, <string-name name-style="western"><surname>Graham</surname><given-names>MS</given-names></string-name>, <string-name name-style="western"><surname>Zsoldos</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Sotiropoulos</surname><given-names>SN</given-names></string-name>. <article-title>Incorporating outlier detection and replacement into a non‚Äêparametric framework for movement and distortion correction of diffusion MR images</article-title>. <source>Neuroimage</source>. <year>2016</year>;<volume>141</volume>:<fpage>556</fpage>‚Äê<lpage>572</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroimage.2016.06.058</pub-id><pub-id pub-id-type="pmid">27393418</pub-id></mixed-citation></ref><ref id="dad212381-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="dad212381-cit-0030"><string-name name-style="western"><surname>Jenkinson</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Beckmann</surname><given-names>CF</given-names></string-name>, <string-name name-style="western"><surname>Behrens</surname><given-names>TEJ</given-names></string-name>, <string-name name-style="western"><surname>Woolrich</surname><given-names>MW</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>SMFSL</given-names></string-name>. <article-title>FSL</article-title>. <source>Neuroimage</source>. <year>2012</year>;<volume>62</volume>(<issue>2</issue>):<fpage>782</fpage>‚Äê<lpage>790</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroimage.2011.09.015</pub-id><pub-id pub-id-type="pmid">21979382</pub-id></mixed-citation></ref><ref id="dad212381-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="dad212381-cit-0031"><string-name name-style="western"><surname>Andersson</surname><given-names>JLR</given-names></string-name>, <string-name name-style="western"><surname>Skare</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Ashburner</surname><given-names>J</given-names></string-name>. <article-title>How to correct susceptibility distortions in spin‚Äêecho echo‚Äêplanar images: application to diffusion tensor imaging</article-title>. <source>Neuroimage</source>. <year>2003</year>;<volume>20</volume>(<issue>2</issue>):<fpage>870</fpage>‚Äê<lpage>888</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S1053-8119(03)00336-7</pub-id><pub-id pub-id-type="pmid">14568458</pub-id></mixed-citation></ref><ref id="dad212381-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="dad212381-cit-0032"><string-name name-style="western"><surname>Fick</surname><given-names>RHJ</given-names></string-name>, <string-name name-style="western"><surname>Wassermann</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Deriche</surname><given-names>R</given-names></string-name>. <article-title>The dmipy toolbox: diffusion MRI multi‚Äêcompartment modeling and microstructure recovery made easy</article-title>. <source>Front Neuroinform</source>. <year>2019</year>;<volume>13</volume>:<fpage>64</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fninf.2019.00064</pub-id><pub-id pub-id-type="pmid">31680924</pub-id><pub-id pub-id-type="pmcid">PMC6803556</pub-id></mixed-citation></ref><ref id="dad212381-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="dad212381-cit-0033"><string-name name-style="western"><surname>Garyfallidis</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Brett</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Amirbekian</surname><given-names>B</given-names></string-name>, et¬†al. <article-title>Dipy, a library for the analysis of diffusion MRI data</article-title>. <source>Front Neuroinform</source>. <year>2014</year>;<volume>8</volume>:<fpage>8</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fninf.2014.00008</pub-id><pub-id pub-id-type="pmid">24600385</pub-id><pub-id pub-id-type="pmcid">PMC3931231</pub-id></mixed-citation></ref><ref id="dad212381-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="dad212381-cit-0034"><string-name name-style="western"><surname>Smith</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Jenkinson</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Johansen‚ÄêBerg</surname><given-names>H</given-names></string-name>, et¬†al. <article-title>Tract‚Äêbased spatial statistics: voxelwise analysis of multi‚Äêsubject diffusion data</article-title>. <source>Neuroimage</source>. <year>2006</year>;<volume>31</volume>(<issue>4</issue>):<fpage>1487</fpage>‚Äê<lpage>1505</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroimage.2006.02.024</pub-id><pub-id pub-id-type="pmid">16624579</pub-id></mixed-citation></ref><ref id="dad212381-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="dad212381-cit-0035"><string-name name-style="western"><surname>Fortin</surname><given-names>JP</given-names></string-name>, <string-name name-style="western"><surname>Cullen</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Sheline</surname><given-names>YI</given-names></string-name>, et¬†al. <article-title>Harmonization of cortical thickness measurements across scanners and sites</article-title>. <source>NeuroImage</source>. <year>2018</year>;<volume>167</volume>:<fpage>104</fpage>‚Äê<lpage>120</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroimage.2017.11.024</pub-id><pub-id pub-id-type="pmid">29155184</pub-id><pub-id pub-id-type="pmcid">PMC5845848</pub-id></mixed-citation></ref><ref id="dad212381-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="dad212381-cit-0036"><string-name name-style="western"><surname>Pomponio</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Erus</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Habes</surname><given-names>M</given-names></string-name>, et¬†al. <article-title>Harmonization of large MRI datasets for the analysis of brain imaging patterns throughout the lifespan</article-title>. <source>NeuroImage</source>. <year>2020</year>;<volume>208</volume>:<elocation-id>116450</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroimage.2019.116450</pub-id><pub-id pub-id-type="pmid">31821869</pub-id><pub-id pub-id-type="pmcid">PMC6980790</pub-id></mixed-citation></ref><ref id="dad212381-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="dad212381-cit-0037"><string-name name-style="western"><surname>Johnson</surname><given-names>WE</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Rabinovic</surname><given-names>A</given-names></string-name>. <article-title>Adjusting batch effects in microarray expression data using empirical Bayes methods</article-title>. <source>Biostatistics</source>. <year>2007</year>;<volume>8</volume>(<issue>1</issue>):<fpage>118</fpage>‚Äê<lpage>127</lpage>. doi:<pub-id pub-id-type="doi">10.1093/biostatistics/kxj037</pub-id><pub-id pub-id-type="pmid">16632515</pub-id></mixed-citation></ref><ref id="dad212381-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="dad212381-cit-0038"><string-name name-style="western"><surname>Winkler</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Ridgway</surname><given-names>GR</given-names></string-name>, <string-name name-style="western"><surname>Webster</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Nichols</surname><given-names>TE</given-names></string-name>. <article-title>Permutation inference for the general linear model</article-title>. <source>Neuroimage</source>. <year>2014</year>;<volume>92</volume>:<fpage>381</fpage>‚Äê<lpage>397</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroimage.2014.01.060</pub-id><pub-id pub-id-type="pmid">24530839</pub-id><pub-id pub-id-type="pmcid">PMC4010955</pub-id></mixed-citation></ref><ref id="dad212381-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="dad212381-cit-0039"><string-name name-style="western"><surname>Smith</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Nichols</surname><given-names>T</given-names></string-name>. <article-title>Threshold‚Äêfree cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference</article-title>. <source>NeuroImage</source>. <year>2009</year>;<volume>44</volume>(<issue>1</issue>):<fpage>83</fpage>‚Äê<lpage>98</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroimage.2008.03.061</pub-id><pub-id pub-id-type="pmid">18501637</pub-id></mixed-citation></ref><ref id="dad212381-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="dad212381-cit-0040"><string-name name-style="western"><surname>Fonov</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Evans</surname><given-names>AC</given-names></string-name>, <string-name name-style="western"><surname>Botteron</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Almli</surname><given-names>CR</given-names></string-name>, <string-name name-style="western"><surname>McKinstry</surname><given-names>RC</given-names></string-name>, <string-name name-style="western"><surname>Collins</surname><given-names>DL</given-names></string-name>. <article-title>Unbiased average age‚Äêappropriate atlases for pediatric studies</article-title>. <source>Neuroimage</source>. <year>2011</year>;<volume>54</volume>(<issue>1</issue>):<fpage>313</fpage>‚Äê<lpage>327</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroimage.2010.07.033</pub-id><pub-id pub-id-type="pmid">20656036</pub-id><pub-id pub-id-type="pmcid">PMC2962759</pub-id></mixed-citation></ref><ref id="dad212381-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="dad212381-cit-0041"><string-name name-style="western"><surname>Wang</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>J</given-names></string-name>, et¬†al. <article-title>Quantification of white matter cellularity and damage in preclinical and early symptomatic Alzheimer's disease</article-title>. <source>Neuroimage Clin</source>. <year>2019</year>;<volume>22</volume>:<elocation-id>101767</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.nicl.2019.101767</pub-id><pub-id pub-id-type="pmid">30901713</pub-id><pub-id pub-id-type="pmcid">PMC6428957</pub-id></mixed-citation></ref><ref id="dad212381-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="dad212381-cit-0042"><string-name name-style="western"><surname>Wu</surname><given-names>YC</given-names></string-name>, <string-name name-style="western"><surname>Alexander</surname><given-names>AL</given-names></string-name>. <article-title>Hybrid diffusion imaging</article-title>. <source>Neuroimage</source>. <year>2007</year>;<volume>36</volume>(<issue>3</issue>):<fpage>617</fpage>‚Äê<lpage>629</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroimage.2007.02.050</pub-id><pub-id pub-id-type="pmid">17481920</pub-id><pub-id pub-id-type="pmcid">PMC2428345</pub-id></mixed-citation></ref><ref id="dad212381-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="dad212381-cit-0043"><string-name name-style="western"><surname>Nasrabady</surname><given-names>SE</given-names></string-name>, <string-name name-style="western"><surname>Rizvi</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Goldman</surname><given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>Brickman</surname><given-names>AM</given-names></string-name>. <article-title>White matter changes in Alzheimer's disease: a focus on myelin and oligodendrocytes</article-title>. <source>Acta Neuropathol Commun</source>. <year>2018</year>;<volume>6</volume>:<fpage>22</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s40478-018-0515-3</pub-id><pub-id pub-id-type="pmid">29499767</pub-id><pub-id pub-id-type="pmcid">PMC5834839</pub-id></mixed-citation></ref><ref id="dad212381-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="dad212381-cit-0044"><string-name name-style="western"><surname>Papuƒá</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Rejdak</surname><given-names>K</given-names></string-name>. <article-title>The role of myelin damage in Alzheimer's disease pathology</article-title>. <source>Arch Med Sci</source>. <year>2018</year>;<volume>16</volume>(<issue>2</issue>):<fpage>345</fpage>‚Äê<lpage>351</lpage>. doi:<pub-id pub-id-type="doi">10.5114/aoms.2018.76863</pub-id><pub-id pub-id-type="pmid">32190145</pub-id><pub-id pub-id-type="pmcid">PMC7069444</pub-id></mixed-citation></ref><ref id="dad212381-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="dad212381-cit-0045"><string-name name-style="western"><surname>Bozzetti</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Ferrari</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Gajofatto</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Mariotto</surname><given-names>S</given-names></string-name>. <article-title>Neurofilament light chain in demyelinating conditions of the central nervous system: a promising biomarker</article-title>. <source>Neuroimmunol Neuroinflammation</source>. <year>2021</year>;<volume>8</volume>(<issue>1</issue>):<fpage>1</fpage>‚Äê<lpage>13</lpage>. <pub-id pub-id-type="doi">10.20517/2347-8659.2020.26</pub-id></mixed-citation></ref><ref id="dad212381-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="dad212381-cit-0046"><string-name name-style="western"><surname>Weinhofer</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Rommer</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Zierfuss</surname><given-names>B</given-names></string-name>, et¬†al. <article-title>Neurofilament light chain as a potential biomarker for monitoring neurodegeneration in X‚Äêlinked adrenoleukodystrophy</article-title>. <source>Nat Commun</source>. <year>2021</year>;<volume>12</volume>(<issue>1</issue>):<fpage>1816</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41467-021-22114-2</pub-id><pub-id pub-id-type="pmid">33753741</pub-id><pub-id pub-id-type="pmcid">PMC7985512</pub-id></mixed-citation></ref><ref id="dad212381-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="dad212381-cit-0047"><string-name name-style="western"><surname>Parks</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Iosif</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Farias</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Reed</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Mungas</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>DeCarli</surname><given-names>C</given-names></string-name>. <article-title>Executive function mediates effects of white matter hyperintensities on episodic memory</article-title>. <source>Neuropsychologia</source>. <year>2011</year>;<volume>49</volume>(<issue>10</issue>):<fpage>2817</fpage>‚Äê<lpage>2824</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuropsychologia.2011.06.003</pub-id><pub-id pub-id-type="pmid">21689669</pub-id><pub-id pub-id-type="pmcid">PMC3402218</pub-id></mixed-citation></ref><ref id="dad212381-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="dad212381-cit-0048"><string-name name-style="western"><surname>Mayo</surname><given-names>CD</given-names></string-name>, <string-name name-style="western"><surname>Garcia‚ÄêBarrera</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Mazerolle</surname><given-names>EL</given-names></string-name>, et¬†al. <article-title>Relationship between DTI metrics and cognitive function in Alzheimer's disease</article-title>. <source>Front Aging Neurosci</source>. <year>2019</year>;<volume>10</volume>:<fpage>436</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fnagi.2018.00436</pub-id><pub-id pub-id-type="pmid">30687081</pub-id><pub-id pub-id-type="pmcid">PMC6333848</pub-id></mixed-citation></ref><ref id="dad212381-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="dad212381-cit-0049"><string-name name-style="western"><surname>Rizvi</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Lao</surname><given-names>PJ</given-names></string-name>, <string-name name-style="western"><surname>Col√≥n</surname><given-names>J</given-names></string-name>, et¬†al. <article-title>Tract‚Äêdefined regional white matter hyperintensities and memory</article-title>. <source>Neuroimage Clin</source>. <year>2020</year>;<volume>25</volume>:<elocation-id>102143</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.nicl.2019.102143</pub-id><pub-id pub-id-type="pmid">31887716</pub-id><pub-id pub-id-type="pmcid">PMC6939088</pub-id></mixed-citation></ref><ref id="dad212381-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="dad212381-cit-0050"><string-name name-style="western"><surname>Wu</surname><given-names>YC</given-names></string-name>, <string-name name-style="western"><surname>Field</surname><given-names>AS</given-names></string-name>, <string-name name-style="western"><surname>Whalen</surname><given-names>PJ</given-names></string-name>, <string-name name-style="western"><surname>Alexander</surname><given-names>AL</given-names></string-name>. <article-title>Age‚Äê and gender‚Äêrelated changes in the normal human brain using hybrid diffusion imaging (HYDI)</article-title>. <source>Neuroimage</source>. <year>2011</year>;<volume>54</volume>(<issue>3</issue>):<fpage>1840</fpage>‚Äê<lpage>1853</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroimage.2010.09.067</pub-id><pub-id pub-id-type="pmid">20932911</pub-id><pub-id pub-id-type="pmcid">PMC3217718</pub-id></mixed-citation></ref><ref id="dad212381-bib-0051"><label>51</label><mixed-citation publication-type="miscellaneous" id="dad212381-cit-0051"><string-name name-style="western"><surname>Fick</surname><given-names>RHJ</given-names></string-name>, <string-name name-style="western"><surname>Pizzolato</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Wassermann</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Zucchelli</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Menegaz</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Deriche</surname><given-names>R</given-names></string-name>. <article-title>A sensitivity analysis of q‚Äêspace indices with respect to changes in axonal diameter, dispersion and tissue composition</article-title>. <year>2016</year>:<fpage>1241</fpage>‚Äê<lpage>1244</lpage>. doi:<pub-id pub-id-type="doi">10.1109/ISBI.2016.7493491</pub-id></mixed-citation></ref><ref id="dad212381-bib-0052"><label>52</label><mixed-citation publication-type="journal" id="dad212381-cit-0052"><string-name name-style="western"><surname>Calvo‚ÄêFlores Guzm√°n</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Elizabeth Chaffey</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Hansika Palpagama</surname><given-names>T</given-names></string-name>, et¬†al. <article-title>The interplay between beta‚Äêamyloid 1‚Äê42 (AŒ≤1‚Äê42)‚Äêinduced hippocampal inflammatory response, p‚Äêtau, vascular pathology, and their synergistic contributions to neuronal death and behavioral deficits</article-title>. <source>Front Mol Neurosci</source>. <year>2020</year>;<volume>13</volume>:<fpage>196</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fnmol.2020.552073</pub-id><pub-id pub-id-type="pmcid">PMC7667153</pub-id><pub-id pub-id-type="pmid">33224025</pub-id></mixed-citation></ref><ref id="dad212381-bib-0053"><label>53</label><mixed-citation publication-type="journal" id="dad212381-cit-0053"><string-name name-style="western"><surname>Sv√§rd</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Nilsson</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Lampinen</surname><given-names>B</given-names></string-name>, et¬†al. <article-title>The effect of white matter hyperintensities on statistical analysis of diffusion tensor imaging in cognitively healthy elderly and prodromal Alzheimer's disease</article-title>. <source>PLoS One</source>. <year>2017</year>;<volume>12</volume>(<issue>9</issue>):<elocation-id>e0185239</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0185239</pub-id><pub-id pub-id-type="pmid">28934374</pub-id><pub-id pub-id-type="pmcid">PMC5608410</pub-id></mixed-citation></ref><ref id="dad212381-bib-0054"><label>54</label><mixed-citation publication-type="journal" id="dad212381-cit-0054"><string-name name-style="western"><surname>Raghavan</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Reid</surname><given-names>RI</given-names></string-name>, <string-name name-style="western"><surname>Przybelski</surname><given-names>SA</given-names></string-name>, et¬†al. <article-title>Diffusion models reveal white matter microstructural changes with ageing, pathology and cognition</article-title>. <source>Brain Commun</source>. <year>2021</year>;<volume>3</volume>(<issue>2</issue>). doi:<pub-id pub-id-type="doi">10.1093/braincomms/fcab106</pub-id><pub-id pub-id-type="pmcid">PMC8202149</pub-id><pub-id pub-id-type="pmid">34136811</pub-id></mixed-citation></ref></ref-list></back></article>